Back
Day Range
$2.33
$2.78
52-Week Range
$1.62
$3.50
Volume
300
50D / 200D Avg
$2.62
/
$2.73
Prev Close
$2.44
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 2.3 | 0.4 |
| P/B | 0.1 | 2.9 |
| ROE % | 6.0 | 3.7 |
| Net Margin % | 6.7 | 3.9 |
| Rev Growth 5Y % | 7.9 | 10.0 |
| D/E | 0.7 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$1.72
$1.55 – $1.86
|
46 B | 1 |
| FY2026 |
$1.62
$1.46 – $1.75
|
44 B | 1 |
Key Takeaways
Revenue grew 7.89% annually over 5 years — modest growth
Earnings grew 16.08% over the past year
Generating 66.79M in free cash flow
P/E of 2.33 — trading at a low valuation
PEG of 0.75 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 8.69%
Growth
Revenue Growth (5Y)
7.89%
Revenue (1Y)-0.80%
Earnings (1Y)16.08%
FCF Growth (3Y)N/A
Quality
Return on Equity
5.96%
ROIC4.03%
Net Margin6.74%
Op. Margin10.34%
Safety
Debt / Equity
0.67
Current Ratio0.92
Interest Coverage2.96
Valuation
P/E Ratio
2.33
P/B Ratio0.14
EV/EBITDA5.80
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.80% | Revenue Growth (3Y) | -3.34% |
| Earnings Growth (1Y) | 16.08% | Earnings Growth (3Y) | -13.84% |
| Revenue Growth (5Y) | 7.89% | Earnings Growth (5Y) | -6.75% |
| Profitability | |||
| Revenue (TTM) | 41.07B | Net Income (TTM) | 2.77B |
| ROE | 5.96% | ROA | 2.36% |
| Gross Margin | 47.97% | Operating Margin | 10.34% |
| Net Margin | 6.74% | Free Cash Flow (TTM) | 66.79M |
| ROIC | 4.03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.67 | Current Ratio | 0.92 |
| Interest Coverage | 2.96 | Dividend Yield | 0.06% |
| Valuation | |||
| P/E Ratio | 2.33 | P/B Ratio | 0.14 |
| P/S Ratio | 0.16 | PEG Ratio | 0.75 |
| EV/EBITDA | 5.80 | Dividend Yield | 0.06% |
| Market Cap | 6.46B | Enterprise Value | 24.63B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 41.07B | 41.40B | 43.95B | 39.01B | 30.31B |
| Net Income | 2.77B | 2.39B | 3.73B | 4.73B | 3.66B |
| EPS (Diluted) | 1.04 | 0.89 | 1.43 | 1.85 | 1.43 |
| Gross Profit | 19.70B | 19.80B | 20.78B | 18.78B | 16.88B |
| Operating Income | 4.25B | 3.31B | 8.30B | 6.31B | 4.72B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 117.46B | 113.47B | 107.16B | 93.29B | 83.69B |
| Total Liabilities | 57.53B | 56.85B | 53.05B | 44.92B | 37.70B |
| Shareholders' Equity | 47.26B | 45.68B | 44.58B | 39.19B | 37.00B |
| Total Debt | 31.70B | 30.28B | 30.25B | 24.25B | 24.01B |
| Cash & Equivalents | 13.52B | 13.69B | 16.24B | 10.31B | 9.96B |
| Current Assets | 34.49B | 33.79B | 35.28B | 30.42B | 25.08B |
| Current Liabilities | 37.45B | 33.76B | 33.30B | 29.31B | 24.87B |